Archives

by in
Entry Author Date Location
Merck on Track to Seek Approval for Two Heart Drugs in ’13 08/27/12 New York
CardioKinetix Clears 2-Year Study with Implant for Heart Failure 05/18/12 San Francisco
NextWave Pharma Snaps Up $45M 01/11/11 San Francisco
BG Medicine Wins FDA OK, Primes Pump for Second Shot at IPO 11/24/10 Boston
$17M for Stent Maker TriReme 10/12/10 San Francisco
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010 09/20/10 San Francisco
Swedish Names Chief Scientist 09/08/10 Seattle
Aastrom Shows Off Vascular Results 06/11/10 Detroit
Arena Loses Merck Collaboration After Clogged-Artery Drug Fails Clinical Trial 12/23/09 San Diego
NormOxys Emerges from Stealth with New Class of Oxygen Drugs for Cancer, Heart Failure 12/04/09 Boston
Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis 01/21/09 San Diego
Page 1 of 1

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.